Semaglutide is a once-weekly injectable medication that acts on GLP-1 receptors to support appetite regulation, improve glycemic control, and promote clinically significant weight loss as part of a medically supervised treatment program.
Our 3-Month Starter Dose Package includes a three-month supply with gradual dose escalation, including 0.25 mg, 0.5 mg, and 1 mg, designed to support safe initiation and adjustment to treatment.
All first-time prescriptions require a telehealth consultation with a licensed M.D. Treatment is provided under the supervision of our medical team, including physicians and registered nurses, to ensure safe and appropriate care throughout your program.